STAP1 and STAP2 inhibit apoptosis of leukaemic stem cells in chronic myeloid leukaemia by binding to BCR-ABL fusion oncoprotein and signal transducer and activator of transcription 5a (STAT5a) [19, 20]. Here, STAT5A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.